ProShares - UltraShort Nasdaq Biotechnology (BIS) Price
ProShares - UltraShort Nasdaq Biotechnology Price
Performance
ETF Holdings by Sector
| Sector | Distribution |
|---|---|
Cash & Others | 100 % |
ProShares - UltraShort Nasdaq Biotechnology List of Holdings
| Company | Share |
|---|---|
Net Other Assets (Liabilities) | 100.00 % |
Frequently asked questions about ProShares - UltraShort Nasdaq Biotechnology
ProShares - UltraShort Nasdaq Biotechnology is offered by ProShares, a leading player in the field of passive investments.
The ISIN of ProShares - UltraShort Nasdaq Biotechnology is US74350P4697.
The total expense ratio of ProShares - UltraShort Nasdaq Biotechnology is 3.20%, which means that investors pay 320.00 USD per 10,000 USD in investment capital annually.
The ETF is listed in USD.
European investors may incur additional costs for currency exchange and transaction fees.
No, ProShares - UltraShort Nasdaq Biotechnology does not comply with the EU UCITS investor protection directives.
ProShares - UltraShort Nasdaq Biotechnology tracks the performance of the NASDAQ / Biotechnology.
The ETF invests in various sectors, with focuses on Cash & Others.
The current average trading volume of ProShares - UltraShort Nasdaq Biotechnology is 7,936.00.
ProShares - UltraShort Nasdaq Biotechnology is domiciled in US.
The fund was launched on 4/7/2010.
The ProShares - UltraShort Nasdaq Biotechnology mainly invests in Healthcare companies.
The NAV of ProShares - UltraShort Nasdaq Biotechnology amounts to 11.72 USD.
Investments can be made through brokers or financial institutions that provide access to trading ETFs.
The ETF is traded on the stock exchange, similar to stocks.
Yes, the ETF can be held in a regular securities account.
The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.
The ETF is valued on a daily stock exchange basis.
Information on dividends should be requested from the provider's website or your broker.
The risks include market fluctuations, currency risks, and the risk associated with smaller companies.
The ETF is obligated to report regularly and transparently on its investments.
The performance can be viewed on Eulerpool or directly on the provider's website.
Further information can be found on the official website of the provider.
ETF profile
ProShares - UltraShort Nasdaq Biotechnology